Erik Danielsen - Net Worth and Insider Trading
Erik Danielsen Net Worth
The estimated net worth of Erik Danielsen is at least $4,573 dollars as of 2024-09-20. Erik Danielsen is the CFO of Nymox Pharmaceutical Corp and owns about 20,900 shares of Nymox Pharmaceutical Corp (NYMXF) stock worth over $4,573. Details can be seen in Erik Danielsen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Erik Danielsen has not made any transactions after 2018-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Erik Danielsen
Erik Danielsen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Erik Danielsen owns 1 companies in total, including Nymox Pharmaceutical Corp (NYMXF) .
Click here to see the complete history of Erik Danielsen’s form 4 insider trades.
Insider Ownership Summary of Erik Danielsen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NYMXF | Nymox Pharmaceutical Corp | 2018-12-21 | Chief Financial Officer |
Erik Danielsen Latest Holdings Summary
Erik Danielsen currently owns a total of 1 stock. Erik Danielsen owns 20,900 shares of Nymox Pharmaceutical Corp (NYMXF) as of December 21, 2018, with a value of $4,573.
Latest Holdings of Erik Danielsen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NYMXF | Nymox Pharmaceutical Corp | 2018-12-21 | 20,900 | 0.22 | 4,573 |
Holding Weightings of Erik Danielsen
Erik Danielsen Form 4 Trading Tracker
According to the SEC Form 4 filings, Erik Danielsen has made a total of 0 transactions in Nymox Pharmaceutical Corp (NYMXF) over the past 5 years. The most-recent trade in Nymox Pharmaceutical Corp is the acquisition of 6,000 shares on December 21, 2018, which cost Erik Danielsen around $8,100.
Insider Trading History of Erik Danielsen
- 1
Erik Danielsen Trading Performance
GuruFocus tracks the stock performance after each of Erik Danielsen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Erik Danielsen is 61.64%. GuruFocus also compares Erik Danielsen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Erik Danielsen within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Erik Danielsen's insider trading performs compared to the benchmark.
Performance of Erik Danielsen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 60.8 | | | | | |
| Relative Return to S&P 500(%) | 52.28 | | | | | |
Erik Danielsen Ownership Network
Erik Danielsen Owned Company Details
What does Nymox Pharmaceutical Corp do?
Who are the key executives at Nymox Pharmaceutical Corp?
Erik Danielsen is the Chief Financial Officer of Nymox Pharmaceutical Corp. Other key executives at Nymox Pharmaceutical Corp include director & 10 percent owner & CEO Paul Averback , and director & General Counsel Randall J Lanham .
Nymox Pharmaceutical Corp (NYMXF) Insider Trades Summary
Over the past 18 months, Erik Danielsen made no insider transaction in Nymox Pharmaceutical Corp (NYMXF). Other recent insider transactions involving Nymox Pharmaceutical Corp (NYMXF) include a net purchase of 120,000 shares made by James George Robinson ,
In summary, during the past 3 months, insiders sold 0 shares of Nymox Pharmaceutical Corp (NYMXF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nymox Pharmaceutical Corp (NYMXF) were sold and 120,000 shares were bought by its insiders, resulting in a net purchase of 120,000 shares.
Nymox Pharmaceutical Corp (NYMXF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nymox Pharmaceutical Corp Insider Transactions
Erik Danielsen Mailing Address
Above is the net worth, insider trading, and ownership report for Erik Danielsen. You might contact Erik Danielsen via mailing address: 9900 Cavendish Blvd, St Laurent A8 H4m 2v2.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
